Media Centre

Featured Media Release

14 Oct 2014 - Indigenous and refugee programs win immunisation boost

GSK’s 2014 Immunisation Grants have been awarded to programs that are helping improve access and awareness of vaccination services for Indigenous and refugee communities.


Media Releases

GSK Awarded Funds to Advance Dermal Treatment with Starpharma’s Dendrimers

GlaxoSmithKline (GSK), and Starpharma (ASX:SPL, OTCQX:SPHRY) today announced that GSK was awarded a grant to advance a dermal treatment based on Starpharma’s dendrimer drug delivery technology.



Worldwide study to help Australians breathe easier needs volunteers

Australian sufferers of chronic obstructive pulmonary disorder (COPD), one of the most important causes of breathlessness and difficulty performing tasks of normal daily life, have the opportunity to participate in a worldwide study, starting this...



PBS listing of new treatment for enlarged prostate

Australian men who suffer from the symptoms of an enlarged prostate – like frequent urination, waking at night to urinate; a sense of incomplete emptying after urination; straining to urinate or a feeling of extreme urgency to urinate1 - now have a...



GSK discloses payments to Australian healthcare professionals

As part of an ongoing commitment to increase transparency, GlaxoSmithKline Australia today disclosed the aggregate amount of fees paid to Australian healthcare professionals and health-related organisations for all sponsorships, grants, speaking...



GSK to disclose payments to healthcare professionals by June 2011

As part of an ongoing commitment to increase transparency, GlaxoSmithKline announced today the intention to publish, by June 2011, the total amount of fees paid to Australian healthcare professionals for speaking and consulting services during 2010.



GSK statement on AvodartTM (dutasteride) for prostate cancer risk reduction

GlaxoSmithKline (GSK) announced today that it will no longer pursue global approval (marketing authorisation) for the use of Avodart® (dutasteride) to reduce the risk of prostate cancer. The Company will withdraw applications from regulatory review...



Twice-yearly osteoporosis treatment Prolia® (denosumab) available on the PBS for postmenopausal women with osteoporosis1

Australian women with postmenopausal osteoporosis – a chronic bone disease that weakens bones and makes them more likely to fracture – now have access to another treatment option as Prolia® (denosumab) is made available on the Pharmaceutical...



Q. Puzzled about vaccination? A.

A new website,, has been launched to provide all Australians with simple, easy to understand information about vaccine-preventable diseases at the time of life when it is most relevant to them.



Sydney manufacturing operations to change

GlaxoSmithKline (GSK) Australia announced today that the manufacture of toothpaste products will cease in Australia, Sydney by December 2011.



GSK Australia Avandia Update

GlaxoSmithKline (GSK) continues to believe that Avandia is an important treatment option for patients with type 2 diabetes, and is not aware of any legal proceedings having been initiated in Australia in respect of Avandia.


< 4 5 6 7 8 9 10 11 12 13 14 >